TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong · Delayed Price · Currency is HKD 92.00
+27.90 (43.53%)
At close: Mar 6, 2026
HKG:2617 Market Cap
HKG:2617 has a market cap or net worth of 36.71 billion as of March 6, 2026.
Market Cap
36.71B
Enterprise Value
36.01B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
92.00
Market Cap Chart
Since June 23, 2025, HKG:2617's market cap has increased from 9.33B to 36.71B, an increase of 293.56%. That is a compound annual growth rate of 610.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 25.58B | -43.92% |
| Dec 31, 2025 | 45.60B | 388.94% |
| Jun 23, 2025 | 9.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Henlius Biotech | 34.78B |
| Shanghai Junshi Biosciences | 32.69B |
| Biocytogen Pharmaceuticals (Beijing) | 31.73B |
| Duality Biotherapeutics | 26.64B |
| Genscript Biotech | 24.12B |
| PegBio | 24.05B |
| InnoCare Pharma | 22.50B |
| Zai Lab | 16.15B |